TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma (GEINOCANN)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03529448 |
|
Recruitment Status :
Not yet recruiting
First Posted : May 18, 2018
Last Update Posted : February 23, 2023
|
Sponsor:
Grupo Español de Investigación en Neurooncología
Collaborators:
Medical Cannabis Bike Tour
Voices Against Brain Cancer
Tilray
Information provided by (Responsible Party):
Grupo Español de Investigación en Neurooncología
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Not yet recruiting |
|---|---|
| Estimated Primary Completion Date : | March 2025 |
| Estimated Study Completion Date : | December 2025 |